News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Middle East conflict extends, lifting oil prices and disrupting Strait of Hormuz maritime traffic.
  • Asian currencies slide and global bond volatility rises as investors price the conflict risk.
  • UBS pushes expected Fed rate cuts to December 2026, citing firmer inflation and jobs data.
  • India mobilizes FX reserves, import curbs and regulatory tools after $20 billion portfolio outflows and rising import costs.
  • Shanghai stocks hit an 11-year peak as Nvidia CEO's presence boosts China tech ahead of the U.S.-China summit.
  • Birkenstock shares plunge over 11% after Q2 revenue and profit missed estimates and a conflict-related EMEA charge.

Latest Articles

Huntington Ingalls Sees Margin Compression as Costs Rise

Huntington Ingalls Sees Margin Compression as Costs Rise

Huntington Ingalls reported a narrower quarterly operating margin as rising costs pressured profitability. Revenue exceeded analyst estimates, driven in part by growth at the Newport News shipyard, but higher product costs and broader trade uncertainty contributed to a decline in margins. Shares traded lower in premarket activity.

MIAX Executive Executes Stock Transactions Amid Rising Trading Volumes

MIAX Executive Executes Stock Transactions Amid Rising Trading Volumes

Edward Deitzel, who serves as the Executive Vice President, Chief Risk Officer, and Chief Compliance Officer for MIAX Exchanges, has completed a series of transactions involving common stock of MIAMI INTERNATIONAL HOLDINGS, INC. (NASDAQ:MIAX). The filings indicate that on May 4, 2026, Mr. Deitzel sold 11,000 shares for a total proceeds of $520,080.…

Virtuix to Lead Infantry Training Project for U.S. Marine Corps

Virtuix to Lead Infantry Training Project for U.S. Marine Corps

Virtuix Inc. (NASDAQ: VTIX) has been chosen by the U.S. Marine Corps Training and Education Command to lead the development and integration of a multi-user virtual reality infantry training system utilizing four Omni One omni-directional treadmills. This system allows a four-person Marine fire team to physically move together in a shared virtual en…

JAKKS Pacific: Quiet Turnaround, Visible Catalysts — Upgrade to Buy

JAKKS Pacific: Quiet Turnaround, Visible Catalysts — Upgrade to Buy

JAKKS Pacific (JAKK) looks mispriced versus the operational improvements and near-term product catalysts on the horizon. With gross margins at a 15-year high, a debt-free balance sheet, and fresh anime and entertainment licensing partnerships, the risk-reward favors a tactical long. This note lays out an entry, stop and target with a mid-term horiz…

Viridian Shares Jump After Elegrobart Phase 3 REVEAL-2 Shows Strong Results

Viridian Shares Jump After Elegrobart Phase 3 REVEAL-2 Shows Strong Results

Viridian Therapeutics stock climbed 40% on Tuesday after the company reported positive topline results from the Phase 3 REVEAL-2 study of elegrobart in chronic thyroid eye disease. Both dosing regimens tested produced statistically significant proptosis responder rates versus placebo at week 24. The therapy was generally well tolerated, and Viridia…

Clorox: High Yield, Cheap Multiple, and a Tactical Long Setup

Clorox: High Yield, Cheap Multiple, and a Tactical Long Setup

Clorox (CLX) is trading near its 52-week low with a 5.7% yield, a mid-teens P/E and free cash flow generation. The stock looks attractive for a tactical long: defendable brands, steady FCF, and a stretched technical setup that favors a recovery if inventory normalization and margin pressure abate. This idea lays out an entry at $86.70, stop at $82.…

RadixArk Secures $100M Seed to Trim AI Inference Costs

RadixArk Secures $100M Seed to Trim AI Inference Costs

RadixArk has raised $100 million in a seed round at a $400 million valuation to advance software that reduces the compute required to run AI models. The round was led by Accel and Spark Capital, with participation from Nvidia’s NVentures, Broadcom CEO Hock Tan, and others. RadixArk's open-source engine, SGLang, operates as a middle layer leveraging…

Morgan Stanley Sees 'Crunch Time' for European Airports, Names Top Picks

Morgan Stanley Sees 'Crunch Time' for European Airports, Names Top Picks

Morgan Stanley describes the European airports sector as entering a "crunch time" driven by regulatory uncertainty, softer retail spending, rising costs and mixed 1Q26 results. Despite modest EBITDA downgrades and near-term execution risks, the broker favors a selective, patient approach and ranks Groupe ADP, Aena, Fraport, Zurich Airport and AIA i…

IZEA Announces Q1 2026 Earnings Results Conference Call

IZEA Announces Q1 2026 Earnings Results Conference Call

IZEA Worldwide, a leading influencer marketing company, announced its financial results conference call for first quarter 2026 will be held on May 12, 2026. The call will be hosted by the CEO and CFO and include a Q&A session. Investors are invited to attend via webcast or phone, with a replay available for a week. The company highlights its positi…

Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer

Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer

Zentalis Pharmaceuticals announced dosing of the first patient in its global Phase 3 ASPENOVA trial evaluating azenosertib, a first-in-class WEE1 inhibitor, against standard chemotherapy in Cyclin E1-positive platinum-resistant ovarian cancer patients. The trial supports a confirmatory study to complement the ongoing Phase 2 DENALI trial aiming for…

Powell Industries Declares Quarterly Cash Dividend

Powell Industries Declares Quarterly Cash Dividend

Powell Industries, a leading provider of custom engineered electrical energy management solutions, declared a quarterly cash dividend of $0.09 per share payable June 17, 2026, to shareholders of record May 20, 2026. The company serves major industries including oil and gas, electric utilities, and industrial markets.

Picard Medical Announces Pricing of $5 Million Offering

Picard Medical Announces Pricing of $5 Million Offering

Picard Medical, Inc., listed on NYSE American as PMI, announced the pricing of a $5 million offering consisting of common stock, pre-funded warrants, and common warrants to institutional investors. The proceeds will be used for working capital, general corporate purposes, and to pay down senior secured notes and working capital loans. The offering …

Apollo Hybrid Value Fund III Raises $6.5 Billion

Apollo Hybrid Value Fund III Raises $6.5 Billion

Apollo Global Management announced the final close of Apollo Hybrid Value Fund III, raising approximately $6.5 billion. The fund attracted a wide range of global institutional investors and focuses on hybrid capital strategies that blend debt and equity features to provide flexible, partnership-oriented investment solutions. This fund follows two p…

Portillo’s Inc. Announces First Quarter 2026 Financial Results

Portillo’s Inc. Announces First Quarter 2026 Financial Results

Portillo's Inc. released its first quarter 2026 financial results showing a 3.5% revenue increase to $182.6 million driven by new restaurant openings. However, same-restaurant sales declined slightly, and the company reported a net loss of $0.5 million compared to net income in the prior year. Operating income and Adjusted EBITDA both fell due to h…